Allergen-specific nasal challenge: Response kinetics of clinical and inflammatory events to rechallenge

International Archives of Allergy and Immunology

Volumn 115, Issue 2, 1998, Pages 157-161

  Ciprandi, Giorgio ^a,c   Ricca, Vittorio ^b   Landi, Massimo ^b   Passalacqua, Giovanni ^a   Bagnasco, Marcello ^a   Canonica, G Walter ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Ospedale Koelliker   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Allergen specific nasal challenge; Inflammation; Rechallenge

Indexed keywords

ALLERGEN;

ADULT; ALLERGY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; EOSINOPHIL; FEMALE; GRASS POLLEN; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MALE; NEUTROPHIL; NOSE PROVOCATION TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYMPTOM;

ADOLESCENT; ADULT; ALLERGENS; EOSINOPHILS; FEMALE; HUMANS; KINETICS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL PROVOCATION TESTS; NEUTROPHILS; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL;

EID: 0031985298     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023896     Document Type: Article

References (12)

1. Naclerio RM, Meier HL, Kagey-Sobotka A: Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128: 597-602.
2. Ciprandi G, Pronzato C, Ricca V, Bagnasco M, Canonica GW: Evidence of ICAM-1 expression on nasal epithelial cells in acute rhinoconjunctivitis due to pollen exposure. J Allergy Clin Immunol 1994;4:738-746.
3. Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Bagnasco M, Canonica GW: Allergen-specific challenge induces intercellular adhesion molecule-1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects: Relationships with early and late inflammatory phenomena. Am J Respir Crit Care Med 1994;150:1653-1659.
4. Mygind N, Dahl R: Challenge tests in nose and bronchi: Pharmacological modulation of rhinitis and asthma. Clin Exp Allergy 1996;26:39-43.
5. Howarth PH: The cellular basis for allergic rhinitis. Allergy 1995;50/23:6-10.
6. Calderon E, Lockey RF: A possible role for adhesion molecules in asthma. J Allergy Clin Immunol 1992;90:852-865.
7. Mygind N, Dahl R: The rational for use of topical corticosteroids in allergic rhinitis. Clin Exp Allergy 1996;26/3:2-10.
8. Mygind N: Glucorticoids and rhinitis. Allergy 1993;48:476-490.
9. Godthelp T, Holm AF, Blom H, Klein-Jan A, Rijntes E, Fokkens WJ: The effect of fluticasone propionate aqueous nasal spray on nasal mucosal inflammation in perennial allergic rhinitis. Allergy 1995;50/23:21-24.
10. Rak S, Jacobson MR, Sudderick RM, Masuyama K, Juliusson S, Kay AB, Hamid Q, Lowhagen O, Durham SR: Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994;24:930-939.
11. Svensson C, Pipkorn U, Alkner U, Baumgarten R, Persson CGA: Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways. Clin Exp Allergy 1992;22:411-416.
12. Passalacqua G, Albano M, Ruffoni S, Pronzato C, Riccio AM, Di Berardino L, Scordamaglia A, Canonica GW: Nasal immunotherapy to parietaria: Evidences of reduction of local allergic inflammation. Am J Respir Crit Care Med 1995;152:461-466.